SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-006366
Filing Date
2022-04-27
Accepted
2022-04-27 16:05:29
Documents
13
Period of Report
2022-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K eras-20220425.htm   iXBRL 8-K 56499
  Complete submission text file 0000950170-22-006366.txt   207838

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20220425_lab.xml EX-101.LAB 16733
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20220425.xsd EX-101.SCH 2912
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20220425_pre.xml EX-101.PRE 12666
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eras-20220425_def.xml EX-101.DEF 13344
7 EXTRACTED XBRL INSTANCE DOCUMENT eras-20220425_htm.xml XML 6173
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 22859501
SIC: 2834 Pharmaceutical Preparations